CIDRAP newsletters options
New viruses had all the building blocks of the human virus, and lab exeriments found that some are equipped with the same capacity to enter human cells.
The world rarely receives advance notice of a significant public health threat, but the detection of the highly pathogenic form of H7N9 avian influenza in China serves as a second warning, an expert from the World Health Organization's collaborating center in Australia said today in a Cell Research commentary.
An international team of researchers has found that a re-engineered rapid molecular test for detection of tuberculosis (TB) is more sensitive than the current test but less specific, according to a study yesterday in The Lancet Infectious Diseases.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Mandating the vaccine is not supported by solid evidence, some experts say.
Resistance in Salmonella may have begun before the antibiotic was ever used in people.
Recent reports of mutations introduced by egg-based flu vaccine production arriving on the heels of a tough flu season in Australia raise worries about a similarly difficult season ahead for the United States, experts said in a New England Journal of Medicine commentary yesterday.
In the largest-ever genetic study of mosquitoes, researchers tracked the movement of insecticide resistance between different African regions and identified several rapidly evolving resistance genes that could be used to develop new tools for tracking resistance, monitoring insecticide use, and developing new control methods. The team from the Wellcome Trust Sanger Institute reporting its findings yesterday in Nature.
The drug-resistant strain has emerged recently on pig farms but has rarely caused human illness.
An estimated 5 million more cases were reported in 2016 than the year before.
Antibiotics administered to mothers during labor to prevent group B Streptococcus infections appear to alter the gut microbiome of newborns, according to a small study yesterday in Scientific Reports.
The effects appeared to resolve within 12 weeks.
The Saudi Arabian Ministry of Health (MOH) today reported a new case of MERS-CoV in Bisha, the third within the last week.
A 67-year-old Saudi woman is in stable condition after presenting with symptoms of MERS-CoV (Middle East respiratory syndrome coronavirus) infection. Her source of infection is listed as "primary," meaning it's unlikely she contracted the virus from another person.
Rates of prevention of recurrent C diff were similar, with fewer side effects.
Japan-based Takeda announces the launch of a phase 1 trial of its Zika vaccine.
The agency reports increased activity overall, 5 pediatric deaths, and a variant H1N1 infection in Iowa.
England has experienced an unprecedented resurgence in scarlet fever infections that began in 2014, but so far the reasons for the escalation aren't clear, researchers from Public Health England reported yesterday in The Lancet Infectious Diseases.
The strain resulted from a mix of high-path H5N8 and low-path H3N6.
Fever, crackling in the lungs, high pulse, and low blood oxygen may be predictive.
The results of a small phase 1 clinical trial show that an activated charcoal product helped protect the gut microbiome in volunteers treated with moxifloxacin, French researchers report in the Journal of Infectious Diseases.
The Saudi Arabian Ministry of Health (MOH) reported two new cases of MERS-CoV over the past week, according to its daily updates on the disease.
